Abstract

Background. Significant amounts of red blood cells (RBCs) transfusions are associated with poor outcome after liver transplantation (LT). We report our series of LT without perioperative RBC (P-RBC) transfusions to evaluate its influence on early and long-term outcomes following LT. Methods. A consecutive series of LT between 2006 and 2011 was analyzed. P-RBC transfusion was defined as one or more RBC units administrated during or ≤48 hours after LT. We divided the cohort in “No-Transfusion” and “Yes-Transfusion.” Preoperative status, graft quality, and intra- and postoperative variables were compared to assess P-RBC transfusion risk factors and postoperative outcome. Results. LT was performed in 127 patients (“No-Transfusion” = 39 versus “Yes-Transfusion” = 88). While median MELD was significantly higher in Yes-Transfusion (11 versus 21; P = 0.0001) group, platelet count, prothrombin time, and hemoglobin were significantly lower. On multivariate analysis, the unique independent risk factor associated with P-RBC transfusions was preoperative hemoglobin (P < 0.001). Incidence of postoperative bacterial infections (10 versus 27%; P = 0.03), median ICU (2 versus 3 days; P = 0.03), and hospital stay (7.5 versus 9 days; P = 0.01) were negatively influenced by P-RBC transfusions. However, 30-day mortality (10 versus 15%) and one- (86 versus 70%) and 3-year (77 versus 66%) survival were equivalent in both groups. Conclusions. Recipient MELD score was not a predictive factor for P-RBC transfusion. Patients requiring P-RBC transfusions had worse postoperative outcome. Therefore, maximum efforts must be focused on improving hemoglobin levels during waiting list time to prevent using P-RBC in LT recipients.

Highlights

  • Liver transplantation (LT) may result in significant blood loss and subsequent transfusion of red blood cells (RBCs) in most patients [1]

  • The need for blood transfusion therapy has remained a critical feature in liver transplantation (LT)

  • To the best of our knowledge, this is the first study investigating the influence of using perioperative RBC (P-RBC) on early and long-term outcomes after LT

Read more

Summary

Introduction

Liver transplantation (LT) may result in significant blood loss and subsequent transfusion of red blood cells (RBCs) in most patients [1]. Anatomical local surgical difficulties, prolonged surgical time, perioperative hypothermia, metabolic derangements, and intraoperative dilutional coagulopathy (blood transfusions and fluid administration) are factors that could potentially increase blood loss during surgery. It is widely known that there is clear association between intraoperative RBC transfusion and survival in LT [4, 5]. Significant surgical blood loss has been linked to major surgical morbidity and operative mortality, whereas RBC transfusion is associated with multiple disadvantages, risks, and increased financial burden. Significant amounts of red blood cells (RBCs) transfusions are associated with poor outcome after liver transplantation (LT). The unique independent risk factor associated with PRBC transfusions was preoperative hemoglobin (P < 0.001). Maximum efforts must be focused on improving hemoglobin levels during waiting list time to prevent using P-RBC in LT recipients

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call